ATP

DSV is a transport and logistics company based in Hedehusene, Denmark, that offers a wide range of transportation services globally, including road, air, sea, and train logistics. Founded in 1976, the company has primarily focused on its European trucking network, as well as airfreight and sea freight forwarding divisions. DSV has experienced significant growth, largely through acquisitions, including the notable purchase of GIL in 2021, which enhanced its revenue diversity and expanded its presence in key regions like the Middle East. This strategic growth has positioned DSV among the top three largest third-party logistics firms worldwide.

MedTrace Pharma A/S, founded in 2015 and based in Kongens Lyngby, Denmark, specializes in the development of innovative solutions for positron emission tomography (PET) imaging. The company has created an automated system, known as MT-100, which efficiently produces and injects 15O-water, a radioactive tracer essential for enhanced imaging. This system is designed to integrate seamlessly with in-house cyclotrons and PET scanners, significantly increasing the sensitivity of patient analysis while improving throughput by up to four times compared to conventional methods. Additionally, MedTrace Pharma develops the aQuant analytical platform, which aids in interpreting PET scan results, further optimizing the diagnostic process. With additional offices in Boston, Massachusetts, and Uppsala, Sweden, MedTrace is focused on advancing the capabilities of clinical imaging through automation and innovative technology.

Veo Technologies ApS specializes in developing video technology that enables the automatic recording and analysis of football matches without the need for a cameraman. Founded in 2015 and based in Copenhagen, Denmark, the company provides a solution that allows clubs, players, coaches, scouts, families, and fans to capture and share high-quality sports footage easily. Veo's platform uses two action cameras that automatically track player and ball movement, producing complete video recordings of matches. This technology eliminates the need for manual video editing, making it accessible and affordable for football clubs of all sizes to stream and review their games.

MedTrace Pharma A/S, founded in 2015 and based in Kongens Lyngby, Denmark, specializes in the development of innovative solutions for positron emission tomography (PET) imaging. The company has created an automated system, known as MT-100, which efficiently produces and injects 15O-water, a radioactive tracer essential for enhanced imaging. This system is designed to integrate seamlessly with in-house cyclotrons and PET scanners, significantly increasing the sensitivity of patient analysis while improving throughput by up to four times compared to conventional methods. Additionally, MedTrace Pharma develops the aQuant analytical platform, which aids in interpreting PET scan results, further optimizing the diagnostic process. With additional offices in Boston, Massachusetts, and Uppsala, Sweden, MedTrace is focused on advancing the capabilities of clinical imaging through automation and innovative technology.

Visiopharm A/S is a Danish company specializing in AI-based image analysis and tissue mining tools for the pathology industry, founded in 2001. The company develops digital pathology solutions that include the Oncotopix scanner for capturing digital images of slides, and a suite of AI-based applications designed for diagnostic and clinical research. Among its offerings are advanced image analysis software, the Visiopharm Viewer for displaying images, the AI Phenotyping module for automating analysis workflows, the Tissuealign module for aligning digitalized serial sections, and VirtualDoubleStain for automating stroma separation. Visiopharm's solutions are widely adopted by leading biopharmaceutical companies, academic medical centers, and research institutes globally, with over 500 licenses in more than 30 countries. The company operates through a network of distributors across Europe, North America, Latin America, Asia, and Australia, and maintains its headquarters in Horsholm, Denmark, with additional offices in Germany, Sweden, the United Kingdom, and the United States.

Visiopharm A/S is a Danish company specializing in AI-based image analysis and tissue mining tools for the pathology industry, founded in 2001. The company develops digital pathology solutions that include the Oncotopix scanner for capturing digital images of slides, and a suite of AI-based applications designed for diagnostic and clinical research. Among its offerings are advanced image analysis software, the Visiopharm Viewer for displaying images, the AI Phenotyping module for automating analysis workflows, the Tissuealign module for aligning digitalized serial sections, and VirtualDoubleStain for automating stroma separation. Visiopharm's solutions are widely adopted by leading biopharmaceutical companies, academic medical centers, and research institutes globally, with over 500 licenses in more than 30 countries. The company operates through a network of distributors across Europe, North America, Latin America, Asia, and Australia, and maintains its headquarters in Horsholm, Denmark, with additional offices in Germany, Sweden, the United Kingdom, and the United States.